SlideShare a Scribd company logo
Analysis of the Breast Cancer
(Familial) Gene and Disease
Association
By: Crystal Thomas
What is Breast Cancer?
• Breast cancer is a type of cancer
that affects the breast region.
• It is said to be affecting one in eight
women and being one of the
leading causes of death in women
in the United States (Medline Plus,
2015).
• Even though it is popular in
women, men may also suffer from
breast cancer in rare cases
(National Cancer Institute, 2015).
Risks
• Gender (Women more often
than men)
• Age
• Race
• Dense breast tissue
• Family history
• Genetics
(American Cancer Society, 2015).
Genetics
• Approximately 5% to 10% of
breast cancers are said to be
caused by family genes passed
on to their children, hence
familial breast cancer (Beast
Cancer.org, 2015).
Genetics (Continuted)
• Familial breast cancer contain
several genes that may have
caused breast cancer formation
in people such as: BRCA1,
BRCA2, ATM, TP53, CHEK2,
PTEN, CDH1, PALB2, RINT1,
RAD50, and NBN (Breast
Cancer.org, 2015).
• Those abnormal genes may also
be present in other diseases as
well.
Genetics (Continued
• PTEN: cancer of digestive tract,
thyroid, uterus, and ovaries
• CDH1: stomach cancer
• BRCA1 and BRCA2: ovarian
cancer and other cancers
• NBN: Nijmegen Breakage
Syndrome (slow growth during
infancy and childhood)
(Breast Cancer.org, 2015)
Hypothesis
• Discovering this has led me to formulate my hypothesis: people with
diseases that have highest amounts of familial breast cancer disease
genes would be more susceptible to having familial breast cancer.
DisGeNet
• I was able to collect data for the
familial breast cancer genes and
disease association by utilizing
DisGeNet, a database that would
incorporate information on
gene-disease association
through public data and
literature sources (Pinero et al.,
2015).
DisGeNet (Continued)
• DisGeNet has overall 381056
disease and gene associations
(16666 genes and 13172 diseases)
(Pinero et al., 2015).
• Since the number of disease and
gene associations are relatively
high, DisGeNet created a score “in
order to rank the associations
based on the supporting evidence”
(Pinero et al., 2015).
• This database can be examined by
using Browse and Search queries
(Pinero et al., 2015).
DisGeNet (Continued)
• In order for me to gather data, I
used the Search query on the
website and selected the
diseases button to type the
specific disease name (Breast
Cancer, Familial).
(DisGeNET Database, 2015)
DisGeNet (Continued)
• I have chosen three types of data to work with for my analysis: All
Diseases that Share Genes, Summary of Disease that Share Genes,
and Summary of Associated Genes.
(DisGeNET Database, 2015)
(DisGeNET
Database, 2015)
(DisGeNET
Database, 2015)
Excel
• All three data were exported to
Microsoft’s Excel program in
order for me to perform data
manipulations to determine the
validity of my hypothesis.
Excel (Continued)
• Since the data contained 3,609
different diseases that contained
familial breast cancer genes, I
decided to create a pivot table
to portray the top 25 diseases
that shared those genes and the
total number of genes that were
included.
• *The table portrayed 26
different diseases since the final
two diseases have the same
number of genes.*
Disease Names Sum of Number Of Shared Genes
Malignant neoplasm breast 107
Breast Carcinoma 105
NEOPLASM MALIGNANT 101
Carcinoma 83
Breast Neoplasms 78
Malignant neoplasm of prostate 76
OVARIAN CARCINOMA 74
Malignant neoplasm of ovary 73
Colorectal Cancer 72
prostate carcinoma 72
Neoplasms 70
Carcinogenesis 70
MALIGNANT LUNG NEOPLASM 67
Neoplasm Metastasis 66
Colorectal Carcinoma 64
Carcinoma, Hepatocellular 62
Melanoma 61
Malignant neoplasm of bladder 60
Carcinoma, Non-Small-Cell Lung 59
Metastatic Neoplasm 59
Adenocarcinoma 59
Ovarian epithelial cancer 58
Tumor Progression 58
Leukemia 57
Colorectal Neoplasms 55
Prostatic Neoplasms 55
Grand Total 1821
Summary of Associated Genes
• I was curious to see which
familial breast cancer gene has
the highest score and to see
which diseases were associated
with that particular gene.
• I found that the BRCA genes
(1&2) were the top Genes
according to DisGeNet’s score
and number of resources found
in Pubmed database.
Disease ID
• On Microsoft Access, my goal was to perform computations and
further manipulations built from work that I have performed using
Excel.
• The Number of Shared Genes Sorted worksheet was imported
through access to receive an ID number for the disease names.
Number of Shared Genes Sorted
Disease ID Disease Names Sum of Number Of Shared Genes
1 Malignant neoplasm breast 107
2 Breast Carcinoma 105
3 NEOPLASM MALIGNANT 101
4 Carcinoma 83
5 Breast Neoplasms 78
6 Malignant neoplasm of prostate 76
7 OVARIAN CARCINOMA 74
8 Malignant neoplasm of ovary 73
9 Colorectal Cancer 72
10 prostate carcinoma 72
11 Neoplasms 70
12 Carcinogenesis 70
13 MALIGNANT LUNG NEOPLASM 67
14 Neoplasm Metastasis 66
15 Colorectal Carcinoma 64
16 Carcinoma, Hepatocellular 62
17 Melanoma 61
18 Malignant neoplasm of bladder 60
19 Carcinoma, Non-Small-Cell Lung 59
20 Metastatic Neoplasm 59
21 Adenocarcinoma 59
22 Ovarian epithelial cancer 58
23 Tumor Progression 58
24 Leukemia 57
25 Colorectal Neoplasms 55
26 Prostatic Neoplasms 55
Gene ID
• Gene ID was sorted in
alphabetical order.
Bridge Table
• The Bridge Table contained both
Disease and Gene ID’s.
Relationships
• Gene and Bridge Tables were
imported into Access from Excel.
• In order to see whether or not
those tables were interrelated,
relationships were formed.
Query
• Since the tables are aware that
they are interrelated, it allowed
me to be able to create a query
to see whether or not I have
accurately integrated the
content from those tables.
Network Analysis
• In order to view familial breast
cancer gene-disease interaction,
I decided to perform a network
analysis with the top 25 diseases
and familial breast cancer genes
by using Pajek network tool.
Network Analysis
2 Degree Centrality
• I noticed that I have lost
one of the vertices, which
was the LHFP gene from
Neoplasm Malignant
disease. This means that
LHFP gene was the only
gene that has less than 2
degree centrality.
VOSviewer
• To provide another visualization
for this analysis, I decided to
import what I have done from
Pajek network program to
VOSviewer.
• The diseases and genes were
ranked according to color. Red
symbolizes the largest node (i.e.
Malignant Neoplasm Breast due
to having most amount of
familial breast cancer genes).
Results
• This table shows that malignant
neoplasm of breast (breast
cancer) has the most amount of
familial breast cancer genes out
of 3,609 diseases.
• According to American Cancer
Society (2015), if a person has
had breast cancer (or malignant
neoplasm of breast) in the past,
that person would have a
“greater chance of getting
another breast cancer.”
Disease Names Sum of Number Of Shared Genes
Malignant neoplasm breast 107
Breast Carcinoma 105
NEOPLASM MALIGNANT 101
Carcinoma 83
Breast Neoplasms 78
Malignant neoplasm of prostate 76
OVARIAN CARCINOMA 74
Malignant neoplasm of ovary 73
Colorectal Cancer 72
prostate carcinoma 72
Neoplasms 70
Carcinogenesis 70
MALIGNANT LUNG NEOPLASM 67
Neoplasm Metastasis 66
Colorectal Carcinoma 64
Carcinoma, Hepatocellular 62
Melanoma 61
Malignant neoplasm of bladder 60
Carcinoma, Non-Small-Cell Lung 59
Metastatic Neoplasm 59
Adenocarcinoma 59
Ovarian epithelial cancer 58
Tumor Progression 58
Leukemia 57
Colorectal Neoplasms 55
Prostatic Neoplasms 55
Grand Total 1821
(DisGeNet Database,
2015)
Results
• The table also revealed that all of
the top 25 diseases are cancer-
related.
• In regards to this result, Dr. Michael
Naughton of Washington School of
Medicine theory was “because the
body’s immune system was
vulnerable to the development of
the first cancer, it may be more
susceptible to the development of
a second cancer” (National
Comprehensive Cancer Network,
2015).
Disease Names Sum of Number Of Shared Genes
Malignant neoplasm breast 107
Breast Carcinoma 105
NEOPLASM MALIGNANT 101
Carcinoma 83
Breast Neoplasms 78
Malignant neoplasm of prostate 76
OVARIAN CARCINOMA 74
Malignant neoplasm of ovary 73
Colorectal Cancer 72
prostate carcinoma 72
Neoplasms 70
Carcinogenesis 70
MALIGNANT LUNG NEOPLASM 67
Neoplasm Metastasis 66
Colorectal Carcinoma 64
Carcinoma, Hepatocellular 62
Melanoma 61
Malignant neoplasm of bladder 60
Carcinoma, Non-Small-Cell Lung 59
Metastatic Neoplasm 59
Adenocarcinoma 59
Ovarian epithelial cancer 58
Tumor Progression 58
Leukemia 57
Colorectal Neoplasms 55
Prostatic Neoplasms 55
Grand Total 1821
(DisGeNet Database,
2015)
59
105
78
70
83
62
59
72
64
55
57
67
107
60
73
76
61
59
101
66
70
74
58
72
55
58
Number of Shared Genes in the Top 25 Diseases
Total
(DisGeNet Database,
2015)
0
20
40
60
80
100
120
Adenocarcinoma
Breast Carcinoma
Breast Neoplasms
Carcinogenesis
Carcinoma
Carcinoma, Hepatocellular
Carcinoma, Non-Small-Cell Lung
Colorectal Cancer
Colorectal Carcinoma
Colorectal Neoplasms
Leukemia
MALIGNANT LUNG NEOPLASM
Malignant neoplasm breastMalignant neoplasm of bladder
Malignant neoplasm of ovary
Malignant neoplasm of prostate
Melanoma
Metastatic Neoplasm
NEOPLASM MALIGNANT
Neoplasm Metastasis
Neoplasms
OVARIAN CARCINOMA
Ovarian epithelial cancer
prostate carcinoma
Tumor Progression
Number of Genes in Top 25 Diseases
(DisGeNet Database,
2015)
Results (Continued)
• According to the Initial_from_DisGeNet worksheet from Excel, there
were many diseases that were not within the top 25 that are
considered non-cancerous (i.e. Anorexia Nervosa (1 familial breast
cancer genes), Abdominal Obesity Metabolic Syndrome (1 familial
breast cancer genes), Cognition Disorder (1 familial breast cancer
genes), and a mental disorder Asperger’s Syndrome (1 familial breast
cancer genes).
(DisGeNet Database,
2015)
• However, majority of the diseases were listed on that table were still
cancer-related. In regards to this result, Dr. Michael Naughton of
Washington School of Medicine theory was “because the body’s
immune system was vulnerable to the development of the first
cancer, it may be more susceptible to the development of a second
cancer” (National Comprehensive Cancer Network, 2015). This led
me to believe that specific genes that were involved in each disease
may increase one’s chance of suffering from familial breast cancer.
Results (continued)
• The results from Table 2 portray
the genes that have all of the top
25 diseases. The results network
analysis from Pajek network tool
showed that all of those genes
have the highest value of 26.
The lowest value was 1, the
LHFP gene, which was taken out
of the network due to it having a
degree of centrality less than 2.
Genes Number of Diseases
FHIT 26
PTEN 26
PCNA 26
PARP1 26
MYC 26
MDM2 26
ATM 26
IGF1 26
RASSF1 26
HIF1A 26
MLH1 26
ESR1 26
ERBB2 26
EGFR 26
CHEK2 26
CCND1 26
CASP8 26
BRCA2 26
BRCA1 26
HRAS 26
XRCC1 26
VEGFA 26
TP53 26
Conclusion
• The results of the analysis suggested that the diseases that have most
amount of familial breast cancer genes may cause one to be more
susceptible to having familial breast cancer. However, it also helped me to
develop another theory: there are some diseases on the initial list that are
not cancerous but may put someone at risk due to a specific gene with the
highest score according to DisGeNet Database. For instance, some
diseases, like obesity, may not be cancer-related, but it does have the
BRCA1 gene (and 41 other familial breast cancer genes) according to
DisGeNet’s database which I have found to be particularly shocking (shown
in the appendix section). One would have never thought that a disease
like obesity to have a gene that was particularly well-known for breast
cancer diagnosis. I believe that there needs to be more research regarding
this surprise discovery.
Conclusion (Continued)
• Ultimately, genes may only account for 5% to 10% of breast cancer
cases (American Cancer Society, 2015). When one decides to perform
research on genetic factors of breast cancer, they should be aware
that there are other risk factors to consider such as lifestyle and
environment, which may trigger the mutation of the familial breast
cancer genes. They also should take into consideration that if
someone has familial breast cancer genes or other risk factors, it does
not necessarily mean that they are guaranteed to suffer from such a
deadly disease sometime in their lives.
Works Cited
• American Cancer Society. (2015). What are the risk factors for breast cancer. Retrieved from:
http://www.cancer.org/cancer/breastcancer/detailedguide/breast-cancer-risk-factors
• BreastCancer.Org. (2015). Genetics. Retrieved from: http://www.breastcancer.org/risk/factors/genetics
• Centers for Disease Control and Prevention. (2015). Cancer prevention. Retrieved from:
http://www.cdc.gov/cancer/dcpc/prevention/index.htm
• DisGeNET Database. (2015). All diseases that share genes [data file]. Available from www.disgenet.org
• DisGeNET Database. (2015). Summary of associated genes [data file]. Available from www.disgenet.org
• DisGeNET Database. (2015). Summary of disease that share genes [data file]. Available from www.disgenet.org
• MedlinePlus. (2015). Breast cancer. Retrieved from: http://www.nlm.nih.gov/medlineplus/breastcancer.html
• National Cancer Institute. (2015). BRCA1 and BRCA2: Cancer risk and genetic testing. Retrieved from:
http://www.cancer.gov/cancertopics/causes-prevention/genetics/brca-fact-sheet
• National Comprehensive Cancer Network. (2015). Understanding your risk of developing secondary cancers. Retrieved from:
http://www.nccn.org/patients/resources/life_after_cancer/understanding.aspx
• Pinero, J. et al. (2015). DisGeNET: a discovery platform for the dynamical exploration of human diseases and their genes. Database
(2015) Vol. 2015: article ID bav028; doi:10.1093/database/bav028

More Related Content

What's hot

Alterations of the genes involved in the PI3K and estrogen-receptor pathways ...
Alterations of the genes involved in the PI3K and estrogen-receptor pathways ...Alterations of the genes involved in the PI3K and estrogen-receptor pathways ...
Alterations of the genes involved in the PI3K and estrogen-receptor pathways ...
Enrique Moreno Gonzalez
 
Us breast cancer therapy market opportunity analysis
Us breast cancer therapy market opportunity analysisUs breast cancer therapy market opportunity analysis
Us breast cancer therapy market opportunity analysis
KuicK Research
 
Breast Cancer in Young Women and its Impact on Reproductive Function
Breast Cancer in Young Women and its Impact on Reproductive FunctionBreast Cancer in Young Women and its Impact on Reproductive Function
Breast Cancer in Young Women and its Impact on Reproductive Function
Apollo Hospitals
 
Breast Cancer Risk Assessment: How and Why
Breast Cancer Risk Assessment:  How and WhyBreast Cancer Risk Assessment:  How and Why
Breast Cancer Risk Assessment: How and Why
Kevin S. Hughes, MD, FACS
 
Bcancer
BcancerBcancer
Bcancer
swatikod
 
Incremental Impact of Breast Cancer SNP Panel on Risk Classification and Scre...
Incremental Impact of Breast Cancer SNP Panel on Risk Classification and Scre...Incremental Impact of Breast Cancer SNP Panel on Risk Classification and Scre...
Incremental Impact of Breast Cancer SNP Panel on Risk Classification and Scre...
Leonard Davis Institute of Health Economics
 
Kibbe One Voice Against Cancer 20170605
Kibbe One Voice Against Cancer 20170605Kibbe One Voice Against Cancer 20170605
Kibbe One Voice Against Cancer 20170605
Warren Kibbe
 
Precision oncology ncabr kibbe oct 2017
Precision oncology ncabr kibbe oct 2017Precision oncology ncabr kibbe oct 2017
Precision oncology ncabr kibbe oct 2017
Warren Kibbe
 
Breastcancer genes-ppt
Breastcancer genes-pptBreastcancer genes-ppt
Breastcancer genes-ppt
Melissa Cautin-Jacobs
 
Brca acog 2017
Brca acog 2017Brca acog 2017
Brca acog 2017
Rosália Coutada
 
BRCA – IMPORTANCE IN HEREDITARY BREAST & OVARIAN CANCER by Dr Sharda Jain
BRCA – IMPORTANCE IN HEREDITARY  BREAST & OVARIAN CANCER by Dr Sharda Jain BRCA – IMPORTANCE IN HEREDITARY  BREAST & OVARIAN CANCER by Dr Sharda Jain
BRCA – IMPORTANCE IN HEREDITARY BREAST & OVARIAN CANCER by Dr Sharda Jain
Lifecare Centre
 
Efrat Levy Lahad : Genetic testing for breast and ovarian cancer
Efrat Levy Lahad : Genetic testing for breast and ovarian cancerEfrat Levy Lahad : Genetic testing for breast and ovarian cancer
Efrat Levy Lahad : Genetic testing for breast and ovarian cancer
breastcancerupdatecongress
 
Atossa Personalized Medicine Slides
Atossa Personalized Medicine SlidesAtossa Personalized Medicine Slides
Atossa Personalized Medicine Slides
Steven Quay, MD, PhD
 
Report Back from ASCO on Metastatic Breast Cancer
Report Back from ASCO on Metastatic Breast CancerReport Back from ASCO on Metastatic Breast Cancer
Report Back from ASCO on Metastatic Breast Cancer
bkling
 
Risk Appraisal Forum 2009 Westman
Risk Appraisal Forum 2009  WestmanRisk Appraisal Forum 2009  Westman
Risk Appraisal Forum 2009 Westman
fondas vakalis
 
BRCA – Importance in Hereditary Breast & Ovarian Cancer
BRCA – Importance in Hereditary  Breast & Ovarian CancerBRCA – Importance in Hereditary  Breast & Ovarian Cancer
BRCA – Importance in Hereditary Breast & Ovarian Cancer
Lifecare Centre
 
Infographic: Breast Cancer and Genetics
Infographic: Breast Cancer and GeneticsInfographic: Breast Cancer and Genetics
Infographic: Breast Cancer and Genetics
Dana-Farber Cancer Institute
 
Breast Cancer: A focus on BRCA Mutations.
Breast Cancer: A focus on BRCA Mutations.Breast Cancer: A focus on BRCA Mutations.
Breast Cancer: A focus on BRCA Mutations.
Mohamed Abdulla
 
Web. hboc visual aids
Web. hboc visual aidsWeb. hboc visual aids
Web. hboc visual aids
Douglas Riegert-Johnson
 
Federal Research & Development for the Florida system Sept 2014
Federal Research & Development for the Florida system Sept 2014 Federal Research & Development for the Florida system Sept 2014
Federal Research & Development for the Florida system Sept 2014
Warren Kibbe
 

What's hot (20)

Alterations of the genes involved in the PI3K and estrogen-receptor pathways ...
Alterations of the genes involved in the PI3K and estrogen-receptor pathways ...Alterations of the genes involved in the PI3K and estrogen-receptor pathways ...
Alterations of the genes involved in the PI3K and estrogen-receptor pathways ...
 
Us breast cancer therapy market opportunity analysis
Us breast cancer therapy market opportunity analysisUs breast cancer therapy market opportunity analysis
Us breast cancer therapy market opportunity analysis
 
Breast Cancer in Young Women and its Impact on Reproductive Function
Breast Cancer in Young Women and its Impact on Reproductive FunctionBreast Cancer in Young Women and its Impact on Reproductive Function
Breast Cancer in Young Women and its Impact on Reproductive Function
 
Breast Cancer Risk Assessment: How and Why
Breast Cancer Risk Assessment:  How and WhyBreast Cancer Risk Assessment:  How and Why
Breast Cancer Risk Assessment: How and Why
 
Bcancer
BcancerBcancer
Bcancer
 
Incremental Impact of Breast Cancer SNP Panel on Risk Classification and Scre...
Incremental Impact of Breast Cancer SNP Panel on Risk Classification and Scre...Incremental Impact of Breast Cancer SNP Panel on Risk Classification and Scre...
Incremental Impact of Breast Cancer SNP Panel on Risk Classification and Scre...
 
Kibbe One Voice Against Cancer 20170605
Kibbe One Voice Against Cancer 20170605Kibbe One Voice Against Cancer 20170605
Kibbe One Voice Against Cancer 20170605
 
Precision oncology ncabr kibbe oct 2017
Precision oncology ncabr kibbe oct 2017Precision oncology ncabr kibbe oct 2017
Precision oncology ncabr kibbe oct 2017
 
Breastcancer genes-ppt
Breastcancer genes-pptBreastcancer genes-ppt
Breastcancer genes-ppt
 
Brca acog 2017
Brca acog 2017Brca acog 2017
Brca acog 2017
 
BRCA – IMPORTANCE IN HEREDITARY BREAST & OVARIAN CANCER by Dr Sharda Jain
BRCA – IMPORTANCE IN HEREDITARY  BREAST & OVARIAN CANCER by Dr Sharda Jain BRCA – IMPORTANCE IN HEREDITARY  BREAST & OVARIAN CANCER by Dr Sharda Jain
BRCA – IMPORTANCE IN HEREDITARY BREAST & OVARIAN CANCER by Dr Sharda Jain
 
Efrat Levy Lahad : Genetic testing for breast and ovarian cancer
Efrat Levy Lahad : Genetic testing for breast and ovarian cancerEfrat Levy Lahad : Genetic testing for breast and ovarian cancer
Efrat Levy Lahad : Genetic testing for breast and ovarian cancer
 
Atossa Personalized Medicine Slides
Atossa Personalized Medicine SlidesAtossa Personalized Medicine Slides
Atossa Personalized Medicine Slides
 
Report Back from ASCO on Metastatic Breast Cancer
Report Back from ASCO on Metastatic Breast CancerReport Back from ASCO on Metastatic Breast Cancer
Report Back from ASCO on Metastatic Breast Cancer
 
Risk Appraisal Forum 2009 Westman
Risk Appraisal Forum 2009  WestmanRisk Appraisal Forum 2009  Westman
Risk Appraisal Forum 2009 Westman
 
BRCA – Importance in Hereditary Breast & Ovarian Cancer
BRCA – Importance in Hereditary  Breast & Ovarian CancerBRCA – Importance in Hereditary  Breast & Ovarian Cancer
BRCA – Importance in Hereditary Breast & Ovarian Cancer
 
Infographic: Breast Cancer and Genetics
Infographic: Breast Cancer and GeneticsInfographic: Breast Cancer and Genetics
Infographic: Breast Cancer and Genetics
 
Breast Cancer: A focus on BRCA Mutations.
Breast Cancer: A focus on BRCA Mutations.Breast Cancer: A focus on BRCA Mutations.
Breast Cancer: A focus on BRCA Mutations.
 
Web. hboc visual aids
Web. hboc visual aidsWeb. hboc visual aids
Web. hboc visual aids
 
Federal Research & Development for the Florida system Sept 2014
Federal Research & Development for the Florida system Sept 2014 Federal Research & Development for the Florida system Sept 2014
Federal Research & Development for the Florida system Sept 2014
 

Similar to Analysis of the breast cancer (familial)

Risk Clinic Module of HughesRiskApps
Risk Clinic Module of HughesRiskApps Risk Clinic Module of HughesRiskApps
Risk Clinic Module of HughesRiskApps
Fernanda Polubriaginof
 
Risk Clinic Module of HughesRiskApps
Risk Clinic Module of HughesRiskAppsRisk Clinic Module of HughesRiskApps
Risk Clinic Module of HughesRiskApps
Kevin S. Hughes, MD, FACS
 
Oncotype dx
Oncotype dxOncotype dx
Oncotype dx
Abhinav Mutneja
 
Prevention of cancer in women
Prevention of cancer in women Prevention of cancer in women
Prevention of cancer in women
vandana bansal
 
Genetic Technologies Biotech Showcase Presentation
Genetic Technologies Biotech Showcase PresentationGenetic Technologies Biotech Showcase Presentation
Genetic Technologies Biotech Showcase Presentation
RedChip Companies, Inc.
 
Genetic Technologies Biotech Showcase Presentation - w/COVID
Genetic Technologies Biotech Showcase Presentation - w/COVIDGenetic Technologies Biotech Showcase Presentation - w/COVID
Genetic Technologies Biotech Showcase Presentation - w/COVID
RedChip Companies, Inc.
 
Dec. Webinar - Tumor vs. Germline Testing: What’s the Difference?
Dec. Webinar - Tumor vs. Germline Testing: What’s the Difference?Dec. Webinar - Tumor vs. Germline Testing: What’s the Difference?
Dec. Webinar - Tumor vs. Germline Testing: What’s the Difference?
Fight Colorectal Cancer
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
bkling
 
Genomics and Metastatic Breast Cancer: Where Are We Today?
Genomics and Metastatic Breast Cancer: Where Are We Today?Genomics and Metastatic Breast Cancer: Where Are We Today?
Genomics and Metastatic Breast Cancer: Where Are We Today?
Dana-Farber Cancer Institute
 
Breast Cancer
Breast CancerBreast Cancer
Breast Cancer
cphcosu
 
Cancer Genetic Counseling Services
Cancer Genetic Counseling ServicesCancer Genetic Counseling Services
Cancer Genetic Counseling Services
Allina Health
 
Performance and Evaluation of Data Mining Techniques in Cancer Diagnosis
Performance and Evaluation of Data Mining Techniques in Cancer DiagnosisPerformance and Evaluation of Data Mining Techniques in Cancer Diagnosis
Performance and Evaluation of Data Mining Techniques in Cancer Diagnosis
IOSR Journals
 
Nov 2017 #CRCWebinar :: Genetic Testing & You
Nov 2017 #CRCWebinar :: Genetic Testing & YouNov 2017 #CRCWebinar :: Genetic Testing & You
Nov 2017 #CRCWebinar :: Genetic Testing & You
Fight Colorectal Cancer
 
Cervical cancer pp
Cervical cancer ppCervical cancer pp
Cervical cancer pp
ipozin
 
Cervical cancer pp
Cervical cancer ppCervical cancer pp
Cervical cancer pp
ipozin
 
When Cells Go Rogue and Become Breast Cancer
When Cells Go Rogue and Become Breast CancerWhen Cells Go Rogue and Become Breast Cancer
When Cells Go Rogue and Become Breast Cancer
bkling
 
A Review on Data Mining Techniques for Prediction of Breast Cancer Recurrence
A Review on Data Mining Techniques for Prediction of Breast Cancer RecurrenceA Review on Data Mining Techniques for Prediction of Breast Cancer Recurrence
A Review on Data Mining Techniques for Prediction of Breast Cancer Recurrence
Dr. Amarjeet Singh
 
Breast Cancer detection.pptx
Breast Cancer detection.pptxBreast Cancer detection.pptx
Breast Cancer detection.pptx
CHANDRAJEETJHA4
 
Cervical cancer pp
Cervical cancer ppCervical cancer pp
Cervical cancer pp
ipozin
 
Cervical cancer pp
Cervical cancer ppCervical cancer pp
Cervical cancer pp
ipozin
 

Similar to Analysis of the breast cancer (familial) (20)

Risk Clinic Module of HughesRiskApps
Risk Clinic Module of HughesRiskApps Risk Clinic Module of HughesRiskApps
Risk Clinic Module of HughesRiskApps
 
Risk Clinic Module of HughesRiskApps
Risk Clinic Module of HughesRiskAppsRisk Clinic Module of HughesRiskApps
Risk Clinic Module of HughesRiskApps
 
Oncotype dx
Oncotype dxOncotype dx
Oncotype dx
 
Prevention of cancer in women
Prevention of cancer in women Prevention of cancer in women
Prevention of cancer in women
 
Genetic Technologies Biotech Showcase Presentation
Genetic Technologies Biotech Showcase PresentationGenetic Technologies Biotech Showcase Presentation
Genetic Technologies Biotech Showcase Presentation
 
Genetic Technologies Biotech Showcase Presentation - w/COVID
Genetic Technologies Biotech Showcase Presentation - w/COVIDGenetic Technologies Biotech Showcase Presentation - w/COVID
Genetic Technologies Biotech Showcase Presentation - w/COVID
 
Dec. Webinar - Tumor vs. Germline Testing: What’s the Difference?
Dec. Webinar - Tumor vs. Germline Testing: What’s the Difference?Dec. Webinar - Tumor vs. Germline Testing: What’s the Difference?
Dec. Webinar - Tumor vs. Germline Testing: What’s the Difference?
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
 
Genomics and Metastatic Breast Cancer: Where Are We Today?
Genomics and Metastatic Breast Cancer: Where Are We Today?Genomics and Metastatic Breast Cancer: Where Are We Today?
Genomics and Metastatic Breast Cancer: Where Are We Today?
 
Breast Cancer
Breast CancerBreast Cancer
Breast Cancer
 
Cancer Genetic Counseling Services
Cancer Genetic Counseling ServicesCancer Genetic Counseling Services
Cancer Genetic Counseling Services
 
Performance and Evaluation of Data Mining Techniques in Cancer Diagnosis
Performance and Evaluation of Data Mining Techniques in Cancer DiagnosisPerformance and Evaluation of Data Mining Techniques in Cancer Diagnosis
Performance and Evaluation of Data Mining Techniques in Cancer Diagnosis
 
Nov 2017 #CRCWebinar :: Genetic Testing & You
Nov 2017 #CRCWebinar :: Genetic Testing & YouNov 2017 #CRCWebinar :: Genetic Testing & You
Nov 2017 #CRCWebinar :: Genetic Testing & You
 
Cervical cancer pp
Cervical cancer ppCervical cancer pp
Cervical cancer pp
 
Cervical cancer pp
Cervical cancer ppCervical cancer pp
Cervical cancer pp
 
When Cells Go Rogue and Become Breast Cancer
When Cells Go Rogue and Become Breast CancerWhen Cells Go Rogue and Become Breast Cancer
When Cells Go Rogue and Become Breast Cancer
 
A Review on Data Mining Techniques for Prediction of Breast Cancer Recurrence
A Review on Data Mining Techniques for Prediction of Breast Cancer RecurrenceA Review on Data Mining Techniques for Prediction of Breast Cancer Recurrence
A Review on Data Mining Techniques for Prediction of Breast Cancer Recurrence
 
Breast Cancer detection.pptx
Breast Cancer detection.pptxBreast Cancer detection.pptx
Breast Cancer detection.pptx
 
Cervical cancer pp
Cervical cancer ppCervical cancer pp
Cervical cancer pp
 
Cervical cancer pp
Cervical cancer ppCervical cancer pp
Cervical cancer pp
 

Recently uploaded

Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptxVestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdfCHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
rishi2789
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
FFragrant
 
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptxThyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachIntegrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Ayurveda ForAll
 
#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...
#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...
#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...
chandankumarsmartiso
 
Top 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in IndiaTop 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in India
Swastik Ayurveda
 
Best Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and IndigestionBest Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and Indigestion
Swastik Ayurveda
 
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
Holistified Wellness
 
Aortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 BernAortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 Bern
suvadeepdas911
 
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of HyperthyroidismRole of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
Dr. Jyothirmai Paindla
 
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
NephroTube - Dr.Gawad
 
Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
Dr. Jyothirmai Paindla
 
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptxREGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
LaniyaNasrink
 
OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1
KafrELShiekh University
 
Adhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.comAdhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.com
reignlana06
 
The Best Ayurvedic Antacid Tablets in India
The Best Ayurvedic Antacid Tablets in IndiaThe Best Ayurvedic Antacid Tablets in India
The Best Ayurvedic Antacid Tablets in India
Swastik Ayurveda
 
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptxEar and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
Sapna Thakur
 
Netter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdfNetter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdf
BrissaOrtiz3
 

Recently uploaded (20)

Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptxVestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
 
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdfCHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
 
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptxThyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
 
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachIntegrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
 
#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...
#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...
#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...
 
Top 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in IndiaTop 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in India
 
Best Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and IndigestionBest Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and Indigestion
 
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
 
Aortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 BernAortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 Bern
 
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of HyperthyroidismRole of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
 
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
 
Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
 
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptxREGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
 
OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1
 
Adhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.comAdhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.com
 
The Best Ayurvedic Antacid Tablets in India
The Best Ayurvedic Antacid Tablets in IndiaThe Best Ayurvedic Antacid Tablets in India
The Best Ayurvedic Antacid Tablets in India
 
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptxEar and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
 
Netter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdfNetter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdf
 

Analysis of the breast cancer (familial)

  • 1. Analysis of the Breast Cancer (Familial) Gene and Disease Association By: Crystal Thomas
  • 2. What is Breast Cancer? • Breast cancer is a type of cancer that affects the breast region. • It is said to be affecting one in eight women and being one of the leading causes of death in women in the United States (Medline Plus, 2015). • Even though it is popular in women, men may also suffer from breast cancer in rare cases (National Cancer Institute, 2015).
  • 3. Risks • Gender (Women more often than men) • Age • Race • Dense breast tissue • Family history • Genetics (American Cancer Society, 2015).
  • 4. Genetics • Approximately 5% to 10% of breast cancers are said to be caused by family genes passed on to their children, hence familial breast cancer (Beast Cancer.org, 2015).
  • 5. Genetics (Continuted) • Familial breast cancer contain several genes that may have caused breast cancer formation in people such as: BRCA1, BRCA2, ATM, TP53, CHEK2, PTEN, CDH1, PALB2, RINT1, RAD50, and NBN (Breast Cancer.org, 2015). • Those abnormal genes may also be present in other diseases as well.
  • 6. Genetics (Continued • PTEN: cancer of digestive tract, thyroid, uterus, and ovaries • CDH1: stomach cancer • BRCA1 and BRCA2: ovarian cancer and other cancers • NBN: Nijmegen Breakage Syndrome (slow growth during infancy and childhood) (Breast Cancer.org, 2015)
  • 7. Hypothesis • Discovering this has led me to formulate my hypothesis: people with diseases that have highest amounts of familial breast cancer disease genes would be more susceptible to having familial breast cancer.
  • 8. DisGeNet • I was able to collect data for the familial breast cancer genes and disease association by utilizing DisGeNet, a database that would incorporate information on gene-disease association through public data and literature sources (Pinero et al., 2015).
  • 9. DisGeNet (Continued) • DisGeNet has overall 381056 disease and gene associations (16666 genes and 13172 diseases) (Pinero et al., 2015). • Since the number of disease and gene associations are relatively high, DisGeNet created a score “in order to rank the associations based on the supporting evidence” (Pinero et al., 2015). • This database can be examined by using Browse and Search queries (Pinero et al., 2015).
  • 10. DisGeNet (Continued) • In order for me to gather data, I used the Search query on the website and selected the diseases button to type the specific disease name (Breast Cancer, Familial). (DisGeNET Database, 2015)
  • 11. DisGeNet (Continued) • I have chosen three types of data to work with for my analysis: All Diseases that Share Genes, Summary of Disease that Share Genes, and Summary of Associated Genes.
  • 15. Excel • All three data were exported to Microsoft’s Excel program in order for me to perform data manipulations to determine the validity of my hypothesis.
  • 16. Excel (Continued) • Since the data contained 3,609 different diseases that contained familial breast cancer genes, I decided to create a pivot table to portray the top 25 diseases that shared those genes and the total number of genes that were included. • *The table portrayed 26 different diseases since the final two diseases have the same number of genes.* Disease Names Sum of Number Of Shared Genes Malignant neoplasm breast 107 Breast Carcinoma 105 NEOPLASM MALIGNANT 101 Carcinoma 83 Breast Neoplasms 78 Malignant neoplasm of prostate 76 OVARIAN CARCINOMA 74 Malignant neoplasm of ovary 73 Colorectal Cancer 72 prostate carcinoma 72 Neoplasms 70 Carcinogenesis 70 MALIGNANT LUNG NEOPLASM 67 Neoplasm Metastasis 66 Colorectal Carcinoma 64 Carcinoma, Hepatocellular 62 Melanoma 61 Malignant neoplasm of bladder 60 Carcinoma, Non-Small-Cell Lung 59 Metastatic Neoplasm 59 Adenocarcinoma 59 Ovarian epithelial cancer 58 Tumor Progression 58 Leukemia 57 Colorectal Neoplasms 55 Prostatic Neoplasms 55 Grand Total 1821
  • 17. Summary of Associated Genes • I was curious to see which familial breast cancer gene has the highest score and to see which diseases were associated with that particular gene. • I found that the BRCA genes (1&2) were the top Genes according to DisGeNet’s score and number of resources found in Pubmed database.
  • 18. Disease ID • On Microsoft Access, my goal was to perform computations and further manipulations built from work that I have performed using Excel. • The Number of Shared Genes Sorted worksheet was imported through access to receive an ID number for the disease names.
  • 19. Number of Shared Genes Sorted Disease ID Disease Names Sum of Number Of Shared Genes 1 Malignant neoplasm breast 107 2 Breast Carcinoma 105 3 NEOPLASM MALIGNANT 101 4 Carcinoma 83 5 Breast Neoplasms 78 6 Malignant neoplasm of prostate 76 7 OVARIAN CARCINOMA 74 8 Malignant neoplasm of ovary 73 9 Colorectal Cancer 72 10 prostate carcinoma 72 11 Neoplasms 70 12 Carcinogenesis 70 13 MALIGNANT LUNG NEOPLASM 67 14 Neoplasm Metastasis 66 15 Colorectal Carcinoma 64 16 Carcinoma, Hepatocellular 62 17 Melanoma 61 18 Malignant neoplasm of bladder 60 19 Carcinoma, Non-Small-Cell Lung 59 20 Metastatic Neoplasm 59 21 Adenocarcinoma 59 22 Ovarian epithelial cancer 58 23 Tumor Progression 58 24 Leukemia 57 25 Colorectal Neoplasms 55 26 Prostatic Neoplasms 55
  • 20. Gene ID • Gene ID was sorted in alphabetical order.
  • 21. Bridge Table • The Bridge Table contained both Disease and Gene ID’s.
  • 22. Relationships • Gene and Bridge Tables were imported into Access from Excel. • In order to see whether or not those tables were interrelated, relationships were formed.
  • 23. Query • Since the tables are aware that they are interrelated, it allowed me to be able to create a query to see whether or not I have accurately integrated the content from those tables.
  • 24. Network Analysis • In order to view familial breast cancer gene-disease interaction, I decided to perform a network analysis with the top 25 diseases and familial breast cancer genes by using Pajek network tool.
  • 26. 2 Degree Centrality • I noticed that I have lost one of the vertices, which was the LHFP gene from Neoplasm Malignant disease. This means that LHFP gene was the only gene that has less than 2 degree centrality.
  • 27. VOSviewer • To provide another visualization for this analysis, I decided to import what I have done from Pajek network program to VOSviewer. • The diseases and genes were ranked according to color. Red symbolizes the largest node (i.e. Malignant Neoplasm Breast due to having most amount of familial breast cancer genes).
  • 28. Results • This table shows that malignant neoplasm of breast (breast cancer) has the most amount of familial breast cancer genes out of 3,609 diseases. • According to American Cancer Society (2015), if a person has had breast cancer (or malignant neoplasm of breast) in the past, that person would have a “greater chance of getting another breast cancer.” Disease Names Sum of Number Of Shared Genes Malignant neoplasm breast 107 Breast Carcinoma 105 NEOPLASM MALIGNANT 101 Carcinoma 83 Breast Neoplasms 78 Malignant neoplasm of prostate 76 OVARIAN CARCINOMA 74 Malignant neoplasm of ovary 73 Colorectal Cancer 72 prostate carcinoma 72 Neoplasms 70 Carcinogenesis 70 MALIGNANT LUNG NEOPLASM 67 Neoplasm Metastasis 66 Colorectal Carcinoma 64 Carcinoma, Hepatocellular 62 Melanoma 61 Malignant neoplasm of bladder 60 Carcinoma, Non-Small-Cell Lung 59 Metastatic Neoplasm 59 Adenocarcinoma 59 Ovarian epithelial cancer 58 Tumor Progression 58 Leukemia 57 Colorectal Neoplasms 55 Prostatic Neoplasms 55 Grand Total 1821 (DisGeNet Database, 2015)
  • 29. Results • The table also revealed that all of the top 25 diseases are cancer- related. • In regards to this result, Dr. Michael Naughton of Washington School of Medicine theory was “because the body’s immune system was vulnerable to the development of the first cancer, it may be more susceptible to the development of a second cancer” (National Comprehensive Cancer Network, 2015). Disease Names Sum of Number Of Shared Genes Malignant neoplasm breast 107 Breast Carcinoma 105 NEOPLASM MALIGNANT 101 Carcinoma 83 Breast Neoplasms 78 Malignant neoplasm of prostate 76 OVARIAN CARCINOMA 74 Malignant neoplasm of ovary 73 Colorectal Cancer 72 prostate carcinoma 72 Neoplasms 70 Carcinogenesis 70 MALIGNANT LUNG NEOPLASM 67 Neoplasm Metastasis 66 Colorectal Carcinoma 64 Carcinoma, Hepatocellular 62 Melanoma 61 Malignant neoplasm of bladder 60 Carcinoma, Non-Small-Cell Lung 59 Metastatic Neoplasm 59 Adenocarcinoma 59 Ovarian epithelial cancer 58 Tumor Progression 58 Leukemia 57 Colorectal Neoplasms 55 Prostatic Neoplasms 55 Grand Total 1821 (DisGeNet Database, 2015)
  • 31. 0 20 40 60 80 100 120 Adenocarcinoma Breast Carcinoma Breast Neoplasms Carcinogenesis Carcinoma Carcinoma, Hepatocellular Carcinoma, Non-Small-Cell Lung Colorectal Cancer Colorectal Carcinoma Colorectal Neoplasms Leukemia MALIGNANT LUNG NEOPLASM Malignant neoplasm breastMalignant neoplasm of bladder Malignant neoplasm of ovary Malignant neoplasm of prostate Melanoma Metastatic Neoplasm NEOPLASM MALIGNANT Neoplasm Metastasis Neoplasms OVARIAN CARCINOMA Ovarian epithelial cancer prostate carcinoma Tumor Progression Number of Genes in Top 25 Diseases (DisGeNet Database, 2015)
  • 32. Results (Continued) • According to the Initial_from_DisGeNet worksheet from Excel, there were many diseases that were not within the top 25 that are considered non-cancerous (i.e. Anorexia Nervosa (1 familial breast cancer genes), Abdominal Obesity Metabolic Syndrome (1 familial breast cancer genes), Cognition Disorder (1 familial breast cancer genes), and a mental disorder Asperger’s Syndrome (1 familial breast cancer genes).
  • 34. • However, majority of the diseases were listed on that table were still cancer-related. In regards to this result, Dr. Michael Naughton of Washington School of Medicine theory was “because the body’s immune system was vulnerable to the development of the first cancer, it may be more susceptible to the development of a second cancer” (National Comprehensive Cancer Network, 2015). This led me to believe that specific genes that were involved in each disease may increase one’s chance of suffering from familial breast cancer.
  • 35. Results (continued) • The results from Table 2 portray the genes that have all of the top 25 diseases. The results network analysis from Pajek network tool showed that all of those genes have the highest value of 26. The lowest value was 1, the LHFP gene, which was taken out of the network due to it having a degree of centrality less than 2. Genes Number of Diseases FHIT 26 PTEN 26 PCNA 26 PARP1 26 MYC 26 MDM2 26 ATM 26 IGF1 26 RASSF1 26 HIF1A 26 MLH1 26 ESR1 26 ERBB2 26 EGFR 26 CHEK2 26 CCND1 26 CASP8 26 BRCA2 26 BRCA1 26 HRAS 26 XRCC1 26 VEGFA 26 TP53 26
  • 36. Conclusion • The results of the analysis suggested that the diseases that have most amount of familial breast cancer genes may cause one to be more susceptible to having familial breast cancer. However, it also helped me to develop another theory: there are some diseases on the initial list that are not cancerous but may put someone at risk due to a specific gene with the highest score according to DisGeNet Database. For instance, some diseases, like obesity, may not be cancer-related, but it does have the BRCA1 gene (and 41 other familial breast cancer genes) according to DisGeNet’s database which I have found to be particularly shocking (shown in the appendix section). One would have never thought that a disease like obesity to have a gene that was particularly well-known for breast cancer diagnosis. I believe that there needs to be more research regarding this surprise discovery.
  • 37. Conclusion (Continued) • Ultimately, genes may only account for 5% to 10% of breast cancer cases (American Cancer Society, 2015). When one decides to perform research on genetic factors of breast cancer, they should be aware that there are other risk factors to consider such as lifestyle and environment, which may trigger the mutation of the familial breast cancer genes. They also should take into consideration that if someone has familial breast cancer genes or other risk factors, it does not necessarily mean that they are guaranteed to suffer from such a deadly disease sometime in their lives.
  • 38. Works Cited • American Cancer Society. (2015). What are the risk factors for breast cancer. Retrieved from: http://www.cancer.org/cancer/breastcancer/detailedguide/breast-cancer-risk-factors • BreastCancer.Org. (2015). Genetics. Retrieved from: http://www.breastcancer.org/risk/factors/genetics • Centers for Disease Control and Prevention. (2015). Cancer prevention. Retrieved from: http://www.cdc.gov/cancer/dcpc/prevention/index.htm • DisGeNET Database. (2015). All diseases that share genes [data file]. Available from www.disgenet.org • DisGeNET Database. (2015). Summary of associated genes [data file]. Available from www.disgenet.org • DisGeNET Database. (2015). Summary of disease that share genes [data file]. Available from www.disgenet.org • MedlinePlus. (2015). Breast cancer. Retrieved from: http://www.nlm.nih.gov/medlineplus/breastcancer.html • National Cancer Institute. (2015). BRCA1 and BRCA2: Cancer risk and genetic testing. Retrieved from: http://www.cancer.gov/cancertopics/causes-prevention/genetics/brca-fact-sheet • National Comprehensive Cancer Network. (2015). Understanding your risk of developing secondary cancers. Retrieved from: http://www.nccn.org/patients/resources/life_after_cancer/understanding.aspx • Pinero, J. et al. (2015). DisGeNET: a discovery platform for the dynamical exploration of human diseases and their genes. Database (2015) Vol. 2015: article ID bav028; doi:10.1093/database/bav028